Product Information
WARFARIN SODIUM 4 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0956 per EA under NDC 00093171610. Its NADAC has been published 577 times since Sep 16, 2015.
FDA first approved this application on Jul 5, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093171610
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
WARFARIN SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA040616FDA Approved
7/5/2006
TE Code
AB
On Market Since
6/9/2015
Pharmacological Classes
Price Statistics
The NADAC for WARFARIN SODIUM 4 MG TABLET has been published 577 times since Sep 16, 2015, and over the history we have for it it has declined 48.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0956 per EA |
|---|---|
| All-time high | $0.1975 (Oct 14, 2015) |
| All-time low | $0.0770 (Jul 17, 2024) |
| 52-week high | $0.0969 |
| 52-week low | $0.0782 |
| Median price | $0.1048 |
| Average price | $0.1104 |
| Largest weekly change | +30.6% (Nov 23, 2022) |
| Weeks tracked | 577 |
| Tracking since | Sep 16, 2015 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Warfarin Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Vitamin K Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of WARFARIN SODIUM 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for WARFARIN SODIUM 4 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.0956 per EA (NDC 00093171610), effective Sep 30, 2026.
How has the price of WARFARIN SODIUM 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for WARFARIN SODIUM 4 MG TABLET has declined 48.7%. It has been tracked across 577 weekly CMS publications since Sep 16, 2015.
What are the highest and lowest recorded NADAC prices for WARFARIN SODIUM 4 MG TABLET?
Since Sep 16, 2015, the NADAC for WARFARIN SODIUM 4 MG TABLET has ranged from a low of $0.0770 (Jul 17, 2024) to a high of $0.1975 (Oct 14, 2015), with a median of $0.1048 per EA.
Are there cheaper alternatives to WARFARIN SODIUM 4 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, JANTOVEN 4 MG TABLET, is $0.0892 per EA — about 7% below WARFARIN SODIUM 4 MG TABLET.
Who manufactures WARFARIN SODIUM 4 MG TABLET?
WARFARIN SODIUM 4 MG TABLET (NDC 00093171610) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.